Compare NTRA & JBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTRA | JBL |
|---|---|---|
| Founded | 2003 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.2B | 27.0B |
| IPO Year | 2015 | 1998 |
| Metric | NTRA | JBL |
|---|---|---|
| Price | $197.88 | $353.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 9 |
| Target Price | $259.07 | ★ $272.33 |
| AVG Volume (30 Days) | ★ 1.4M | 1.0M |
| Earning Date | 05-07-2026 | 06-16-2026 |
| Dividend Yield | N/A | ★ 0.10% |
| EPS Growth | ★ 0.65 | N/A |
| EPS | N/A | ★ 3.43 |
| Revenue | $210,939,000.00 | ★ $25,282,320,000.00 |
| Revenue This Year | $18.08 | $15.81 |
| Revenue Next Year | $19.65 | $9.76 |
| P/E Ratio | ★ N/A | $103.71 |
| Revenue Growth | N/A | ★ 14.42 |
| 52 Week Low | $131.81 | $161.52 |
| 52 Week High | $256.36 | $372.37 |
| Indicator | NTRA | JBL |
|---|---|---|
| Relative Strength Index (RSI) | 46.96 | 60.99 |
| Support Level | $187.27 | $201.06 |
| Resistance Level | $204.34 | $372.37 |
| Average True Range (ATR) | 10.36 | 13.59 |
| MACD | -1.12 | -1.23 |
| Stochastic Oscillator | 28.02 | 60.94 |
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
Jabil Inc. is a U.S based company providing engineering, manufacturing, and supply chain solutions. It provides comprehensive electronics design, production, and product management services to companies in various industries and end markets. It operates through three segments: Regulated Industries, serving automotive, healthcare, and renewables; Intelligent Infrastructure, focused on AI, cloud, data centers, and communications, driving the majority of revenue; and Connected Living and Digital Commerce, specializing in digitalization and automation, such as robotics and warehouse automation. The company operates in the U.S., Mexico, China, Malaysia, Singapore, and several other markets.